| Q78194481 | A new HPLC technique for the separation of methocarbamol enantiomers |
| Q85192202 | A reverse phase HPLC method for the separation of two stereo isomers of 2‐[4‐(methylsulfonyl)phenyl]‐3‐(3(r)‐oxocyclopentyl)propanoic acid |
| Q89910177 | A thorough analysis of the effect of surfactant/s on the solubility and pharmacokinetics of (S)-zaltoprofen |
| Q44794462 | Analysis of competitive binding of ligands to human serum albumin using NMR relaxation measurements. |
| Q68631795 | Analysis of drugs and other toxic substances in biological samples for pharmacokinetic studies |
| Q87367441 | Anion effect on the binary and ternary phase diagrams of chiral medetomidine salts and conglomerate crystal formation |
| Q73077485 | Application and comparison of derivatized cellulose and amylose chiral stationary phases for the separation of enantiomers of pharmaceutical compounds by high-performance liquid chromatography |
| Q41565334 | Bioequivalence of chiral drugs. Stereospecific versus non-stereospecific methods |
| Q33352960 | Biomedical applications of chiral liquid chromatography |
| Q44288511 | Central composite design as a powerful optimisation technique for enantioresolution of the rac-11-dihydrooracin--the principal metabolite of the potential cytostatic drug oracin |
| Q44537348 | Chiral analysis of neurotransmitters using cyclodextrin-modified capillary electrophoresis equipped with microfabricated interdigitated electrodes. |
| Q34344756 | Chiral drugs: an overview |
| Q68326560 | Chiral stationary phase designed for β-blockers |
| Q37973723 | Chirality and anaesthetic drugs: A review and an update |
| Q33630484 | Chirality and drugs used in psychiatry: nice to know or need to know? |
| Q40579187 | Chirality in new drug development. Clinical pharmacokinetic considerations |
| Q38730316 | Clinical pharmacokinetic considerations in the elderly. An update |
| Q37905434 | Clinical pharmacokinetics 1990. |
| Q36115910 | Clinical pharmacokinetics of calcium antagonists. An update |
| Q34358841 | Clinical pharmacology through the looking glass: reflections on the racemate vs enantiomer debate |
| Q72031290 | Comparison of the potencies of (+)- and (-)-2-ethylhexanoic acid in causing peroxisome proliferation and related biological effects in mouse liver |
| Q80213630 | Determination of bevantolol enantiomers in human plasma by coupled achiral-chiral high performance-liquid chromatography |
| Q68348602 | Determination of drug enantiomers in biological samples by coupled column liquid chromatography and liquid chromatography-mass spectrometry |
| Q79741903 | Determination of enantiomeric purity by simultaneous dual circular dichroism and ultraviolet spectroscopy |
| Q68781928 | Determination of the enantiomers of suprofen and [2H3]suprofen in plasma by capillary gas chromatography-mass spectrometry |
| Q73538333 | Determination of ticarcillin epimers in plasma and urine with high-performance liquid chromatography |
| Q40903080 | Development and registration of chiral drugs |
| Q68834733 | Development of direct stereoselective and non-stereoselective assays in biological fluids for the enantiomers of a thieno[2,3-b]thiopyran-2-sulfonamide, a topically effective carbonic anhydrase inhibitor |
| Q34175745 | Effects of Antiparkinsonian Drugs on Muscarinic Receptor Binding in Rat Brain, Heart and Lung |
| Q44626182 | Effects of alcohol mobile-phase modifiers on the structure and chiral selectivity of amylose tris(3,5-dimethylphenylcarbamate) chiral stationary phase |
| Q83208620 | Enantioselective 2-hydroxylation of RS-8359, a selective and reversible MAO-A inhibitor, by cytochrome P450 in mouse and rat liver microsomes |
| Q34328918 | Etodolac clinical pharmacokinetics |
| Q43648617 | High-performance liquid chromatographic assay for the simultaneous determination of lansoprazole enantiomers and metabolites in human liver microsomes. |
| Q38790686 | Implications of chirality and geometric isomerism in some psychoactive drugs and their metabolites |
| Q31115254 | In vitro assessment of stereoselective hepatic metabolism of disopyramide in humans: Comparison with in vivo data |
| Q52072800 | Influence of stereoselective pharmacokinetics in the development and predictability of an IVIVC for the enantiomers of metoprolol tartrate. |
| Q69752315 | Isothermal capillary gas chromatography with electron-capture detection of heptafluorobutyryl-L-prolyl derivatives of chiral amphetamines |
| Q52238230 | Lack of stereoselectivity in the pharmacokinetics and metabolism of the radiosensitizer Ro 03-8799 in man. |
| Q83232809 | Mode of Action Studies on a Chiral Diphenyl Ether Peroxidizing Herbicide: Correlation between Differential Inhibition of Protoporphyrinogen IX Oxidase Activity and Induction of Tetrapyrrole Accumulation by the Enantiomers |
| Q37544345 | Molecular asymmetry and its pharmacological consequences |
| Q78194473 | Muscle relaxant activity of methocarbamol enantiomers in mice |
| Q34100441 | Neurochemical and metabolic aspects of antidepressants: an overview |
| Q68506534 | Nonsteroidal anti-inflammatory drugs |
| Q43615881 | Percutaneous absorption of the montoterperne carvone: implication of stereoselective metabolism on blood levels |
| Q77780861 | Pharmaceutical development and specification of stereoisomers |
| Q56620130 | Pharmacokinetics and Metabolism of Bisoprolol Enantiomers in Humans |
| Q28282551 | Pharmacokinetics of (+)-rolipram and (-)-rolipram in healthy volunteers |
| Q39513598 | Pharmacokinetics of calcium antagonists under development |
| Q41598967 | Pharmacological importance of stereochemical resolution of enantiomeric drugs |
| Q42685494 | Plasma and red blood cell pharmacokinetics of pimobendan enantiomers in healthy Chinese |
| Q84584275 | Potential errors in the volume of distribution estimation of therapeutic proteins composed of differently cleared components |
| Q44347186 | Potential of alpha-amino alcohol p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, regarding its enantiomers |
| Q46494887 | Preparation of Enantiomerically Pure (S)-(-)-1-(1'-naphthyl)-ethanol by the Fungus Alternaria alternata |
| Q73426648 | Production and characterization of polyclonal anti-S 20499 antibodies: influence of the hapten structure on stereospecificity |
| Q47374993 | Production of (R)-1-(1,3-benzodioxol-5-yl)ethanol in high enantiomeric purity by Lactobacillus paracasei BD101. |
| Q42563932 | Quantifying crystal form content in physical mixtures of (+/-)-tartaric acid and (+)-tartaric acid using near infrared reflectance spectroscopy |
| Q41057043 | R-Modafinil exerts weak effects on spatial memory acquisition and dentate gyrus synaptic plasticity. |
| Q34618855 | Racemic therapeutics--ethical and regulatory aspects |
| Q41621073 | Relationship between physical properties and crystal structures of chiral drugs |
| Q68330635 | Resolution and Electrophysiological Effects of Mexiletine Enantiomers |
| Q93027100 | Resolution of (R,S)-ibuprofen catalyzed by immobilized Novozym40086 in organic phase |
| Q35871814 | Sedation and histamine H1-receptor antagonism: studies in man with the enantiomers of chlorpheniramine and dimethindene |
| Q74303341 | Separation and quantitation of the S-(+)-enantiomer in the bulk drug tiagabine x HCl by chiral high-performance-liquid chromatography using a Chiralcel-OD column |
| Q32066307 | Separation of amino acid and peptide stereoisomers by nonionic micelle-mediated capillary electrophoresis after chiral derivatization |
| Q77506366 | Separation of the S(+) and R(-)-enantiomers of tiagabine.HCl and its two chiral precursors by chiral chromatography: application to chiral inversion studies |
| Q48093311 | Simple Isocratic HPLC Method for Determination of Enantiomeric Impurity in Besifloxacin Hydrochloride. |
| Q80686717 | Stereoisomeric separation of pharmaceutical compounds using CE with a chiral crown ether |
| Q40886048 | Stereoisomers and drug toxicity. The value of single stereoisomer therapy |
| Q51616395 | Stereoselective Metabolism of Halothane Enantiomers to Trifluoroacetylated Liver Proteins |
| Q41147406 | Stereoselective and carrier-mediated transport of monocarboxylic acids across Caco-2 cells |
| Q43585308 | Stereoselective binding and degradation of sulbenicillin in the presence of human serum albumin |
| Q46247646 | Stereoselective binding properties of naproxen glucuronide diastereomers to proteins |
| Q41977092 | Stereoselective central nervous system effects of the R- and S-isomers of the GABA uptake blocker N-(4, 4-di-(3-methylthien-2-yl)but-3-enyl) nipecotic acid in the rat. |
| Q73204572 | Stereoselective disposition and chiral inversion of KE-298, a new antirheumatic drug, in rats |
| Q69468102 | Stereoselective disposition of flupentixol: influence on steady-state plasma concentrations in schizophrenic patients |
| Q72729263 | Stereoselective dissolution of propranolol hydrochloride from hydroxypropyl methylcellulose matrices |
| Q36442244 | Stereoselective drug disposition: potential for misinterpretation of drug disposition data. |
| Q41534728 | Stereoselective interactions of organic cations with the organic cation transporter in OK cells |
| Q33893154 | Stereoselective metabolism of the monoterpene carvone by rat and human liver microsomes |
| Q36430906 | Stereoselective peripheral sensory neurotoxicity of diaminocyclohexane platinum enantiomers related to ormaplatin and oxaliplatin |
| Q45259933 | Stereoselective pharmacokinetics of RS-8359, a selective and reversible MAO-A inhibitor, by species-dependent drug-metabolizing enzymes |
| Q71455359 | Stereoselective pharmacokinetics of [14C]-labeled KE-298, a new anti-rheumatic drug, in rats |
| Q73327737 | Stereoselective pharmacokinetics of bisoprolol after intravenous and oral administration in beagle dogs |
| Q73636112 | Stereoselective pharmacokinetics of ibuprofen in rats: effect of enantiomer-enantiomer interaction in plasma protein binding |
| Q42064858 | Stereoselective pharmacokinetics of oral and intravenous nitrendipine in healthy male subjects |
| Q41830551 | Stereoselective pharmacokinetics of tocainide in human uraemic patients and in healthy subjects |
| Q37946823 | Stereoselectivity in clinical pharmacokinetics and drug development |
| Q37229338 | Stereoselectivity in pharmacokinetics: a general theory |
| Q68061879 | Stereoselectivity, a natural aspect of molecular biology: a blind spot in clinical pharmacology and pharmacokinetics |
| Q67852164 | Stereospecific high-performance liquid chromatographic assay of sotalol in plasma |
| Q69376362 | Stereospecific liquid chromatographic analysis of racemic adrenergic drugs utilizing precolumn derivatization with (-)-menthyl chloroformate |
| Q73490692 | Studies on synthesis, chromatographic resolution, and antiinflammatory activities of some 2-thioxo-1,2,3,4-tetrahydropyrimidines and their condensed derivatives |
| Q44321138 | Synthesis and in vitro calcium antagonist activity of 4-aryl-7,7-dimethyl/1,7,7-trimethyl-1,2,3,4,5,6,7,8-octahydroquinazoline-2,5-dione derivatives |
| Q44956613 | The FDA perspective on the development of stereoisomers |
| Q40432576 | The cost benefit ratio of enantiomeric drugs |
| Q44304965 | The enantiomers of the teratogenic thalidomide analogue EM 12: 1. Chiral inversion and plasma pharmacokinetics in the marmoset monkey |
| Q43204911 | The pharmacokinetics of the enantiomers of flurbiprofen in patients with rheumatoid arthritis |
| Q34402549 | Use of pseudoracemic nitrendipine to elucidate the metabolic steps responsible for stereoselective disposition of nitrendipine enantiomers |
| Q91000339 | Whole cell application of Lactobacillus paracasei BD101 to produce enantiomerically pure (S)-cyclohexyl(phenyl)methanol |
| Q69035355 | [Are combinations of local anesthetics dangerous?] |